To coincide with World Asthma Day, which falls on May 2, Tuesday, this year, clinical researchers from Sidra Medicine, a member of Qatar Foundation and Hamad Medical Corporation (HMC) have published an examination of the growing prevalence of paediatric asthma cases in Qatar; including data on the rising rates of allergic rhinitis and eczema.

The study, funded by HMC and led by Prof Ibrahim Janahi, chair of Medical Education and Division Chief of Pulmonology at Sidra Medicine, collected data from more than 6500 participants across Qatar. This included nearly 2650 children, split into groups aged between six to seven (6-7) years and 13-14 years, as well as 3831 parents or guardians.

Compared to a previous study conducted by Prof Janahi (ISAAC study), the latest study reported on prevalence rate differences over more than a decade (2005-2017) and showed a noticeable increase in diagnosed asthma (34.6% vs. 19.8%) and diagnosed eczema rates (37.4% vs. 22.5%). However this was not the case for allergic rhinitis which remained the same (30.9% vs. 30.5%).

While the overall findings of the study were found to be consistent with the upward trend found in similar studies conducted in Saudi Arabia, the UAE, and Kuwait; the rates of asthma in school children were higher in Qatar. In addition, the findings of the Qatar-based study are concurrent with the increase in prevalence rates reported in other areas in the world, such as Mexico, South Africa and Bangkok, Latin America and Africa.

Prof Janahi stressed: “In Qatar, there are a number of schools enrolled in the Asthma-friendly Schools Programme, a fantastic initiative from the Ministry of Public Health in collaboration with the Ministry of Education and Higher Eduation. We also want to advise parents that if they are concerned about their children having asthma or allergies to first visit their primary care physician instead of going to the emergency department, except if the child has an asthma attack. Qatar has a robust referral system in place to ensure children have access to the right care at the right time.”

Dr Samer Hammoudeh, post-doctoral research scientist at HMC, one of the authors of the study, said: “Although there is no cure for asthma, with good management, people living with asthma can lead normal, active lives. The findings of this study will help inform and support our ongoing commitment to ensure we have the very latest treatments and the best services in place for children diagnosed with asthma and their parents.”

Dr Yahya Hani, research specialist from the Medical Services Division at Sidra Medicine, who was also one of the authors of the study added: “ It is important to understand that the parameters and the methodologies for collecting the data have changed over the past decade. And although the study was not designed to explore potential reasons for the rising case numbers, it is recommended that future research focuses on looking into the various factors contributing to the cases of asthma, allergic rhinitis, and eczema in Qatar.”